Hint mode is switched on Switch off
For swift navigation between sections

Tianjin ZhongXin Pharmaceutical Group
LEI 300300KHA32RYXJS8249

PDF download

Choose all Reset all
Download Cancel
Organization name
Tianjin ZhongXin Pharmaceutical Group Corp Ltd
Country name
China
Country of registration
China
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Tianjin Zhongxin Pharmaceutical Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Group also manufactures gene-related biopharmaceutical products. Tianjin Zhongxin markets its products under the Great Wall, Cypress, and Health brand names.

Awards

News

12/05/2025 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited: Indicative Announcement on Convening the 2024 Annual General Meeting
20/01/2025 TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: Announcement on the Implementation of Repurchase and Cancellation of the A-share Restricted Stock Incentive Plan for 2019
29/09/2024 Haleon Raising Stake in Tianjin TSKF Pharmaceutical JV to 88%
11/09/2024 Tianjin Pharmaceutical Da Ren Tang to Invest 493.6 Million Yuan in Tianjin Pharmaceutical Group Taiping Medicine
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    300300KHA32RYXJS8249
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
Registration is required to get access.